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DFor as this ought, or ought not, expresses some new
relation or affirmation, ‘tis necessary that it should
be observed and explained; and at the same time
that a reason should be given. how this new relation
can be a deduction from others, which are entirely
different from it.
David Hume, A Treatise of Human Nature, 1739
The place of endovascular stent grafting in the treatment
of Marfan syndrome remains unclear; for that matter, so is
the place of endovascular stent grafting in acute dissection.
Accordingly, the data presented in this study are of interest
to the cardiovascular surgical community. Despite ‘‘expert
consensus’’ that stent grafts should not be used in patients
with connective tissue disorders, we are all seeing more pa-
tients in whom they have been used either in ignorance of
the underlying condition or in emergency salvage condi-
tions. The morbidity associated with descending thoracic
and thoracoabdominal aortic aneurysm disease occurring
as a late sequela of dissection is driving application of the
‘‘frozen elephant trunk’’ operation. These authors have ex-plored both and conclude ‘‘that this procedure is feasible.’’
The question, of course, is whether it is advisable.
The authors have followed 44 Marfan patients with acute
(n ¼ 19) or chronic (n ¼ 25) dissection. Short-term results
were acceptable; importantly, there were no instances of
paraplegia. Follow-up, however, was only 38  17 months.
During this period there were 2 deaths and 1 patient re-
quired thoracoabdominal aortic replacement. Computed to-
mographic scanning demonstrated thrombosis around the
stent graft, but below that level in only 45%. Furthermore,
aortic enlargement—the result of true interest—occurred in
3 of the 19 patients with acute dissection and 6 of the surviv-
ing 23 patients with chronic dissection. The stent graft ex-
tended into the false lumen in 4 of those with acute
dissection. The question is, then, is this success?
One runs the risk of appearing a Luddite when criticizing
the use of novel technology. And, of course, it is always
more comfortable to sit in the camp of conventional wisdom
while another has the courage to challenge dogma. It is not
my aim to impune the authors’ efforts to advance the treat-
ment of this challenging group of patients. We do, however,
need to draw a distinction between therapy that should be
considered ‘‘experimental’’ and most appropriate in the set-
ting of a carefully monitored prospective study, and a new
standard of care. What is apparent is that we can perform
this procedure. What remains unknown is whether we
should.rdiovascular Surgery c Volume 142, Number 3 e91
